Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Thescientificworldjournal|November 19, 2014
Sodium bicarbonate therapy in patients with metabolic acidosisMaría M Adeva-Andany, Carlos Fernández-Fernández, David Mouriño-Bayolo, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Hypoxia-Induced Insulin Resistance Mediates the Elevated Cardiovascular Risk in Patients with Obstructive Sleep Apnea: A Comprehensive ReviewMaría M Adeva-Andany, Alberto Domínguez-Montero, Elvira Castro-Quintela, et al.
Diabetes & Metabolic Syndrome|July 25, 2019
Insulin resistance is a cardiovascular risk factor in humansMaría M Adeva-Andany, Julia Martínez-Rodríguez, Manuel González-Lucán, et al.
Journal of Clinical & Translational Endocrinology|January 9, 2019
Metabolic effects of glucagon in humansMaría M Adeva-Andany, Raquel Funcasta-Calderón, Carlos Fernández-Fernández, et al.
Current Diabetes Reviews|November 18, 2021
Insulin Resistance is Associated with Clinical Manifestations of Diabetic Kidney Disease (Glomerular Hyperfiltration, Albuminuria, and Kidney Function Decline)María M Adeva-Andany, Carlos Fernández-Fernández, Raquel Funcasta-Calderón, et al.
Clinical Nutrition ESPEN|November 4, 2019
Dietary habits contribute to define the risk of type 2 diabetes in humansMaría M Adeva-Andany, Eva Rañal-Muíño, Matilde Vila-Altesor, et al.
Current Reviews in Clinical and Experimental Pharmacology|May 6, 2025
Interferon Causes Endothelial Injury in HumansMaria M Adeva-Andany, Lucía Adeva-Contreras, Carlos Fernandez-Fernandez, et al.
Pflugers Archiv : European Journal of Physiology|June 1, 2023
The metabolic effects of APOL1 in humansMaría M Adeva-Andany, Raquel Funcasta-Calderón, Carlos Fernández-Fernández, et al.
Current Diabetes Reviews|March 19, 2024
Interferon Upregulation Associates with Insulin Resistance in HumansMaria M Adeva-Andany, Natalia Carneiro-Freire, Elvira Castro-Quintela, et al.
Journal of Cardiovascular Pharmacology|April 6, 2022
Cardiovascular Protection Associated With Cilostazol, Colchicine, and Target of Rapamycin InhibitorsMaría M Adeva-Andany, Carlos Fernández-Fernández, Natalia Carneiro-Freire, et al.
Pageof 2